Literature DB >> 1233222

On the pharmacokinetics of phenacetin in man.

J Raaflaub, U C Dubach.   

Abstract

The pharmacokinetic characteristics of the analgesic phenacetin have been determined in six healthy adults. After rapid i.v. injection of 250 mg phenacetin, the log plasma concentrations versus time curves were evaluated according to the rules of a two-compartment open model. The elimination half-life (t1/2)beta varied from 37 to 74 minutes. The volume of distribution (Vd)beta ranged from 1.0 to 2.1 1 per kg body weight. The total clearance of the drug was high and approximated the average value of hepatic blood flow in normal adults. In agreement with this finding, the bioavailability of a small oral dose of phenacetin (0.25 g) was almost nil, as the bulk of the drug was cleared during its first pass through the liver. With large oral doses (1.0 g) the first-pass effect decreased and availability increased. The results are discussed and related to current general views of the liver-first-pass phenomenon.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1233222     DOI: 10.1007/bf00567125

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  12 in total

1.  The estimation of acetanilide and its metabolic products, aniline, N-acetyl p-aminophenol and p-amino-phenol, free and total conjugated, in biological fluids and tissues.

Authors:  B B BRODIE; J AXELROD
Journal:  J Pharmacol Exp Ther       Date:  1948-09       Impact factor: 4.030

2.  The fate of acetophenetidin in man and methods for the estimation of acetophenetidin and its metabolites in biological material.

Authors:  B B BRODIE; J AXELROD
Journal:  J Pharmacol Exp Ther       Date:  1949-09       Impact factor: 4.030

Review 3.  [Pathogenesis of chronic interstitial nephritis following prolonged analgesic abuse].

Authors:  J Raaflaub; U C Dubach
Journal:  Klin Wochenschr       Date:  1972-05-15

4.  Influence of route of administration on drug availability.

Authors:  M Rowland
Journal:  J Pharm Sci       Date:  1972-01       Impact factor: 3.534

5.  Pharmacokinetic basis for the influence of route of administration on the area under the plasma concentration-time curve.

Authors:  M Gibaldi; S Feldman
Journal:  J Pharm Sci       Date:  1969-12       Impact factor: 3.534

6.  Dose-dependent change in the pattern of phenacetin metabolism in man and its possible significance in analgesic nephropathy.

Authors:  J Raaflaub; U C Dubach
Journal:  Klin Wochenschr       Date:  1969-12-01

7.  [New aspects on the question of phenacetin nephrotoxicity].

Authors:  U C Dubach; J Raaflaub
Journal:  Experientia       Date:  1969-09-15

8.  Influence of the route of administration on the area under the plasma concentration-time curve.

Authors:  P A Harris; S Riegelman
Journal:  J Pharm Sci       Date:  1969-01       Impact factor: 3.534

9.  Influence of first-pass effect on availability of drugs on oral administration.

Authors:  M Gibaldi; R N Boyes; S Feldman
Journal:  J Pharm Sci       Date:  1971-09       Impact factor: 3.534

10.  Decreased concentration of phenacetin in plasma of cigarette smokers.

Authors:  E J Pantuck; R Kuntzman; A H Conney
Journal:  Science       Date:  1972-03-17       Impact factor: 47.728

View more
  12 in total

Review 1.  Dietary effects on drug metabolism and transport.

Authors:  Robert Z Harris; Graham R Jang; Shirley Tsunoda
Journal:  Clin Pharmacokinet       Date:  2003       Impact factor: 6.447

2.  Metabolism of paracetamol and phenacetin in relation to debrisoquine oxidation phenotype.

Authors:  M E Veronese; S McLean
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

3.  Pharmacokinetics from a dynamical systems point of view.

Authors:  J M van Rossum; J E de Bie; G van Lingen; H W Teeuwen
Journal:  J Pharmacokinet Biopharm       Date:  1989-06

4.  Dose dependent pharmacokinetics of midazolam.

Authors:  L D Bornemann; B H Min; T Crews; M M Rees; H P Blumenthal; W A Colburn; I H Patel
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953

5.  The contribution of genetically determined oxidation status to inter-individual variation in phenacetin disposition.

Authors:  H W Devonshire; I Kong; M Cooper; T P Sloan; J R Idle; R L Smith
Journal:  Br J Clin Pharmacol       Date:  1983-08       Impact factor: 4.335

6.  Oral prednisone for chronic active liver disease: dose responses and bioavailability studies.

Authors:  M Uribe; S W Schalm; W H Summerskill; V L Go
Journal:  Gut       Date:  1978-12       Impact factor: 23.059

7.  Dose dependence of the 14C-aminopyrine breath test. Intrasubject comparison of tracer and pharmacological doses.

Authors:  I Gikalov; J Bircher
Journal:  Eur J Clin Pharmacol       Date:  1977-11-14       Impact factor: 2.953

8.  A kinetic evaluation of 14CO2 in expired air after 14C-methacetin administration in rats, used for the in vivo study of the metabolism of drugs.

Authors:  D P Thornhill; C Steffen; K J Netter
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1984 Apr-Jun       Impact factor: 2.441

9.  Pharmacokinetics of lorcainide in man: a new antiarrhythmic agent.

Authors:  U Klotz; P Müller-Seydlitz; P Heimburg
Journal:  Clin Pharmacokinet       Date:  1978 Sep-Oct       Impact factor: 6.447

10.  Xenobiotics shape the physiology and gene expression of the active human gut microbiome.

Authors:  Corinne Ferrier Maurice; Henry Joseph Haiser; Peter James Turnbaugh
Journal:  Cell       Date:  2013-01-17       Impact factor: 41.582

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.